653 VONOPRAZAN-BASED DUAL AND TRIPLE THERAPY VERSUS BISMUTHBASED QUADRUPLE THERAPY AS FIRST-LINE THERAPY FOR HELICOBACTER PYLORI INFECTION IN CHINA: A THREE-ARMED, RANDOMIZED CLINICAL TRIAL
Leggi →
Maggio 2024
Risultati per: Trattamento dell'infezione da Helicobacter Pylori
Questo è quello che abbiamo trovato per te
572 REDUCTION OF DISPARITIES IN H. PYLORI TREATMENT AND ERADICATION FOLLOWING IMPLEMENTATION OF A MULTIDISCIPLINARY TREATMENT PROGRAM.
Leggi →
Maggio 2024
Sa1378 HELICOBACTER PYLORI ERADICATION TREATMENT REGIMEN SELECTION FOR PATIENTS WITH DECREASED RENAL FUNCTION: A SYSTEMATIC REVIEW
Leggi →
Maggio 2024
Sa1386 GENETIC VARIANTS OF HELICOBATER PYLORI THAT ARE RESISTANT TO FURAZOLIDONE AND RIFAMPICIN IN COLOMBIA
Leggi →
Maggio 2024
Sa1389 EFFICACY OF NOVEL POTASSIUM-COMPETITIVE ACID BLOCKERS, VONOPRAZAN AND FEXUPRAZAN, VERSUS CONVENTIONAL PROTON PUMP INHIBITOR-BASED TRIPLE THERAPY FOR ERADICATION OF HELICOBACTER PYLORI, A RETROSPECTIVE COHORT STUDY IN A PHILIPPINE TERTIARY HOSPITAL
Leggi →
Maggio 2024
Sa1388 EFFICACY OF VONOPRAZAN-BASED TRIPLE THERAPY VERSUS PROTON PUMP INHIBITOR-BASED SEQUENTIAL AND CONCOMITANT THERAPIES AS FIRST-LINE TREATMENTS FOR HELICOBACTER PYLORI INFECTION: A PROPENSITY SCORE MATCHING ANALYSIS
Leggi →
Maggio 2024
Sa1385 TAILORED THERAPY GUIDED BY GENOTYPIC RESISTANCE BASED ON GASTRIC MUCOSAL SPECIMENS IN THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Leggi →
Maggio 2024
Sa1384 VONOPRAZAN-AMOXICILLIN DUAL THERAPY VERSUS BISMUTH-BASED QUADRUPLE THERAPY FOR TREATMENT OF HELICOBACTER PYLORI INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Leggi →
Maggio 2024
Sa1383 QUADRUPLE AND DUAL THERAPIES ARE SUPERIOR TO STANDARD CLARITHROMYCIN-BASED TRIPLE THERAPY FOR HELICOBACTER PYLORI FIRST-LINE ERADICATION THERAPY USED IN THE LATIN AMERICAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-LATAMREG).
Leggi →
Maggio 2024
Sa1382 TREATMENT OF HELICOBACTER PYLORI WITH POTASSIUM COMPETITIVE ACID BLOCKERS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Leggi →
Maggio 2024
Sa1381 EVALUATION OF IMMUNOGENICITY OF A NOVEL MULTI EPITOPEBASED VACCINE AGAINST HELICOBACTER PYLORI
Leggi →
Maggio 2024
Sa1380 ANTI-INFLAMMATORY PROPERTIES OF FEXUPRAZAN VIA NF-κB INHIBITION AGAINST HELICOBACTER PYLORI CAGA-INDUCED INFLAMMATION
Leggi →
Maggio 2024
Sa1379 ERADICATION RATES OF EMPIRIC HELICOBACTER PYLORI TREATMENT REGIMENS IN A U.S. SAFETY-NET POPULATION
Leggi →
Maggio 2024
Tu1903 HELICOBACTER PYLORI INFECTION AND INCREASED RISK OF NEW-ONSET PRIMARY SJOGREN'S SYNDROME: A POPULATION-BASED COHORT STUDY
Leggi →
Maggio 2024
120 HELICOBACTER PYLORI INFECTION INCREASES APOPTOTIC CELL DEATH AND EPITHELIAL TURNOVER OF THE GASTRIC EPITHELIUM, RECRUITING DENDRITIC CELLS FOR ANTIGEN SAMPLING
Leggi →
Maggio 2024
235 HELICOBACTER PYLORI-INDUCED FERROPTOSIS CONTRIBUTES TO ATROPHIC GASTRITIS VIA MODULATING SELENIUM UTILIZATION BY GPX4.
Leggi →
Maggio 2024
